The Gross Margin of Recro Pharma Inc (REPH) is 2630.44%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2021-12-31 | 2630.44% |
2020-12-31 | 18.60% |
2019-12-31 | 48.62% |
2018-12-31 | 44.20% |
2017-12-31 | 46.83% |
2016-12-31 | 46.42% |
2015-12-31 | 46.01% |